Skip to content
To the full analysis

Core Laboratories stock: balance sheet and debt

CLB
$9.01Closing price of 12 Nov 2026MEQIRI Score 44 out of 100

Core Laboratories has a debt to equity ratio of 0.6 and an interest coverage of 5.3x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.6
Interest coverage
5.3x
Current ratio
2.02
Cash & equivalents
$22.7M
Total assets
$584.01M
Equity ratio
46.6%
Goodwill
$105.79M
Plus intangible assets of $7.12M
Net debt
$141.32M

Total assets and equity ratio

How large the balance sheet of Core Laboratories N.V. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$501.22M$139.22M$132.62M14.6%$248.54M
2007$504.79M$145.84M$138.8M12.6%$277.41M
2008$537.65M$155.59M$148.6M29.8%$202.52M
2009$658.17M$155.12M$148.6M42.8%$28.07M
2010$636.04M$162.88M$154.22M46.0%$22.53M
2011$605.14M$171.01M$162.79M30.0%$196.09M
2012$636.52M$172.06M$163.34M30.4%$214.85M
2013$661.01M$174.29M$163.34M26.5%$241.91M
2014$675.65M$175.11M$164.46M14.9%$332.65M
2015$625.26M$188.2M$178.16M−2.9%$408.49M
2016$573.05M$188.98M$179.04M27.8%$201.72M
2017$584.81M$188.44M$179.04M26.1%$212.59M
2018$648.83M$232.47M$219.41M25.4%$276.65M
2019$774.67M$230.88M$213.43M23.5%$370.69M
2020$568.58M$108.03M$99.45M13.3%$313.17M
2021$580.85M$107.58M$99.45M27.7%$232.56M
2022$578.35M$106.93M$99.45M32.7%$206.96M
2023$586.4M$106.37M$99.45M39.2%$200.27M
2024$590.41M$105.85M$99.45M43.7%$160.99M
2025$584.01M$112.91M$105.79M46.6%$141.32M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$54.22M$71.84M$302.76M4.13
2007$25.62M$62.14M$303.03M4.76
2008$36.14M$158.15M$238.66M1.49
2009$181.05M$279.37M$209.11M0.74
2010$133.88M$289.49M$156.41M0.54
2011$29.33M$177.9M$225.42M1.24
2012$19.23M$187.91M$234.07M1.21
2013$25.09M$169.39M$267M1.52
2014$23.35M$93.99M$356M3.55
2015$22.49M−$23.7M$430.99M−23.51
2016$14.76M$155.3M$216.49M1.36
2017$14.4M$148.73M$226.99M1.49
2018$13.12M$160.9M$289.77M1.76
2019$11.09M$177.87M$381.78M2.1
2020$13.81M$71.51M$326.98M4.33
2021$17.7M$156.45M$250.26M1.55
2022$15.43M$184.26M$222.39M1.18
2023$15.12M$224.82M$215.39M0.94
2024$19.16M$251.99M$180.14M0.7
2025$22.7M$265.99M$164.02M0.6

Debt to equity divides debt by total equity, including non-controlling interests, as S&P calculates it. The equity column shows the part that belongs to shareholders.

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 11 Sep 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy